| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pulmonary Heart Disease | D011660 | 2 associated lipids |
| Diseases in Twins | D004200 | 4 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Bartter Syndrome | D001477 | 5 associated lipids |
| Carotid Artery Thrombosis | D002341 | 7 associated lipids |
| Aortic Aneurysm | D001014 | 8 associated lipids |
| Respiratory Syncytial Virus Infections | D018357 | 10 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Alcoholic Intoxication | D000435 | 15 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ross S et al. | Association of cyclooxygenase-2 genetic variant with cardiovascular disease. | 2014 | Eur. Heart J. | pmid:24796340 |
| pmid:24671522 | ||||
| Song WL et al. | Niacin and biosynthesis of PGDâ‚‚by platelet COX-1 in mice and humans. | 2012 | J. Clin. Invest. | pmid:22406532 |
| Skarke C et al. | Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. | 2012 | Clin. Pharmacol. Ther. | pmid:22278334 |
| Wennmalm A et al. | Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. | 1990 | Clin. Sci. | pmid:2176952 |
| Lynch CM et al. | The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. | 2011 | Prostaglandins Other Lipid Mediat. | pmid:21723954 |
| Piret A et al. | Increased platelet aggregability and prostacyclin biosynthesis induced by intense physical exercise. | 1990 | Thromb. Res. | pmid:2140206 |
| Edlund A et al. | Acipimox stimulates skin blood flow by a cyclo-oxygenase-dependent mechanism. | 1990 | Eur. J. Clin. Pharmacol. | pmid:2125938 |
| Henriksson P et al. | Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo. | 1990 | Prostaglandins | pmid:2106716 |
| Ylikorkala O et al. | Urinary excretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. | 1990 | Prostaglandins | pmid:2106714 |
| Yuhki K et al. | [Prostaglandin I2 and its metabolites]. | 2010 | Nippon Rinsho | pmid:20960743 |
| Fukushima H et al. | Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin. | 2010 | Am. J. Med. Genet. A | pmid:20583254 |
| Hotter G et al. | Altered levels of tissue and urinary prostacyclin in rats subjected to pancreas transplantation. | 1991 | Prostaglandins | pmid:2052738 |
| Vernon WB | Prostaglandins and pancreas transplantation. | 1991 | Prostaglandins | pmid:2052737 |
| Blatnik M and Steenwyk RC | Quantification of urinary PGEm, 6-keto PGF(1alpha) and 2,3-dinor-6-keto PGF(1alpha) by UFLC-MS/MS before and after exercise. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20416393 |
| Wennmalm A et al. | Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. | 1991 | Circulation | pmid:2022025 |
| Rasmanis G et al. | Prostacyclin production in myocardial infarction in the acute phase and during follow-up. | 1991 | J. Intern. Med. | pmid:1997639 |
| Foudi N et al. | Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits. | 2009 | Am. J. Physiol. Heart Circ. Physiol. | pmid:19783781 |
| Greer IA et al. | Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation. | 1990 May-Jun | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:1970789 |
| Ward PS et al. | Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1. | 1991 | Br. J. Pharmacol. | pmid:1933130 |